Merrimack Pharm (MACK) Posts Wider than Expected Q4 Loss

March 14, 2013 8:10 AM EDT Send to a Friend

Merrimack Pharm (NASDAQ: MACK) reported Q4 EPS of ($1.76), $1.50 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Merrimack Pharm (MACK) Posts Wider than Expected Q4 Loss

Member Login

Free News Feed